Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 5R01DA042859-04 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives.
The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing.
The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants).
The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Provider-level push report notifications | Experimental | Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site. |
|
| No intervention | No Intervention | Sites who did not sign Exhibit B-1. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Push reports | Behavioral | Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Opioid Prescribed Following the Intervention | Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data. | up to 5 months from enrollment |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jennifer F Waljee, MD | University of Michigan | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Provider-level Push Report Notifications | Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site. Push reports: Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc. |
| FG001 | No Intervention | Sites who did not sign Exhibit B-1. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Provider-level Push Report Notifications | Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site. Push reports: Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Data on Age was not collected for participants. MSQC does not collect this data for surgeons. |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Change in Opioid Prescribed Following the Intervention | Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data. | Posted | Mean | Standard Deviation | Morphine Milligram Equivalents (MME) | up to 5 months from enrollment |
|
5 months during which the prescribing for each participant was assessed
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Provider-level Push Report Notifications | Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site. Push reports: Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Jennifer Waljee | University of Michigan | (734) 936-8925 | filip@med.umich.edu |
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Aug 2, 2023 | Nov 2, 2023 | Prot_000.pdf |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| BG001 | No Intervention | Sites who did not sign Exhibit B-1. |
| BG002 | Total | Total of all reporting groups |
Data on Age was not collected for participants (surgeon participant). MSQC does not collect this data for surgeons.
| Mean |
| Standard Deviation |
| Years |
|
| Sex: Female, Male | Data on Sex was not collected for participants (surgeon participants). MSQC does not collect this data for surgeons. | Data on Sex was not collected for participants (surgeon participants). MSQC does not collect this data for surgeons. | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Prescribing Practices | Results represent average number of opioid doses (measured in oral morphine equivalents or OMEs) prescribed by surgeon participants that exceed current guidelines of more than 1 pill (7.5 opioid oral morphine milligram equivalent or MMEs). | Mean | Standard Deviation | Morphine Milligram Equivalents (MME) |
|
| OG001 | No Intervention | Sites who did not sign Exhibit B-1. |
|
|
|
| 0 |
| 95 |
| 0 |
| 95 |
| 0 |
| 95 |
| EG001 | No Intervention | Sites who did not sign Exhibit B-1. | 0 | 122 | 0 | 122 | 0 | 122 |
Not provided
Not provided
Not provided